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ABSTRACT
Group A streptococcus (GAS) bacteraemia is often associated with soft-tissue infection, with signiﬁcant
morbidity and mortality. Little is known concerning the differences between adults and children with
GAS bacteraemia. Records for 98 of 116 cases of GAS bacteraemia (60 adults and 38 children, aged
7 days to 96 years) occurring during a 10-year period (1993–2002) were located and reviewed. GAS
bacteraemia comprised 0.6% of all bacteraemias in adults, compared to 3.3% in children (p < 0.001). The
rate of adult GAS bacteraemia was two cases ⁄ 1000 hospitalisations, compared to 13/1000 in children
(p < 0.001). Seventy-six (78%) patients had concomitant tissue involvement, with skin or soft-tissue
infection being the most common (62%). Fifty-three (88%) of 60 adults and ﬁve (13%) of 38 children had
underlying conditions (p < 0.001). Twelve patients died, only one of whom was a child. Parameters
associated with mortality were older age, lower temperature, hypotension, a need for surgical
intervention, toxic shock syndrome, disseminated intravascular coagulation, thrombocytopenia,
lymphopenia, hypocalcaemia, renal failure and acidosis (p < 0.05).
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INTRODUCTION
The spectrum of symptoms associated with group
A streptococcus (GAS) bacteraemia ranges in
severity from a simple febrile illness to life-
threatening infection. GAS bacteraemia probably
results from the penetration of skin organisms
following minor skin abrasions or trauma, and is
often associated with soft-tissue infection such as
cellulitis. Occasionally, it is associated with toxic
shock syndrome or necrotising fasciitis, leading to
signiﬁcant morbidity and mortality. Most epide-
miological studies of GAS bacteraemia have been
performed in adult populations [1–6]. However,
several studies among children have demonstra-
ted an increase in GAS bacteraemia and its
associated mortality [7,8]. There is a paucity of
data on the clinical features of children with
invasive GAS disease, and on the epidemiological
and clinical characteristics of this disease, in
comparison with adult patients. Therefore, the
present study aimed to evaluate the epidemio-
logical and clinical characteristics of patients with
GAS bacteraemia, with particular attention to the
possible differences between adults and children.
MATERIALS AND METHODS
Study design
The study was performed in Shaare Zedek Medical Center, a
550-bed university-afﬁliated general hospital (the second
largest hospital in Jerusalem, Israel). Most patients are
admitted through the emergency department, where c.
75 000 patients are seen annually. The annual admission rate
rose from 24 000 in 1993 to 38 000 in 2002. The paediatric
department contains c. 40 beds, two of which are for
intensive care patients. The paediatric admission rate rose
from 1700 to 3000 per annum during the 10-year period of
the study.
The microbiology laboratory receives c. 20 000 blood cul-
ture sets per annum, and these are processed in a BACTEC
9240 (Becton Dickinson Diagnostic Instrument Systems,
Sparks, MD, USA). Date of culture, the patient’s identiﬁcation
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number, department, organisms isolated, the number of
positive blood cultures from which the same organism was
isolated, and the results of susceptibility tests, are collated in a
database. For epidemiological analysis in the present study, an
organism isolated from any patient was considered only once,
even though the same organism may have been grown from
more than one culture set. Growth of coagulase-negative
Staphylococcus spp., diphtheroids, Bacillus spp., Micrococcus
spp. and a-haemolytic streptococci in blood cultures was
considered signiﬁcant only if the same organism was isolated
from multiple cultures, or from a clinically compatible event
such as endocarditis.
All records of patients with GAS bacteraemia between
1 January 1993 and 31 December 2002 were reviewed. Data
regarding clinical manifestations and laboratory results were
extracted from the medical record of each study patient;
records of children (aged < 18 years) were compared with
those of adults.
Bacteriological methods
Clinical isolates of GAS were identiﬁed by conventional
methods; identiﬁcations were veriﬁed and the isolates were
typed on the basis of their M-protein by the National
Streptococcal Reference Laboratory of the Israel Ministry of
Health.
Statistical methods
Statistical analysis was performed using SigmaStat for Win-
dows Advisory Statistical Program v. 3.0 (SPSS Inc., Chicago,
IL, USA). Qualitative variants were compared by chi-square
test. Qualitative variants that had more than three possible
values, or that contained frequencies < 5 in chequerboard
tables, were calculated using Fisher’s exact test. Quantitative
variables were compared by the t-test. When normality tests
failed, the variables were compared using the Mann–Whitney
U–Wilcoxon test. Variables found to be signiﬁcant (p < 0.05)
were analysed further by multivariate analysis with backward
stepwise logistic regression.
RESULTS
Epidemiology of GAS bacteraemia
During the 10-year study period, there were
10 476 clinically signiﬁcant positive blood cul-
tures, of which 9339 (89%) were from adults and
1137 (11%) were from children. Of these patients,
116 (1.1%) had GAS bacteraemia. Eighteen med-
ical records were not available, and those patients
were excluded from further analysis. The remain-
ing 98 records for 60 (61%) adults and 38 (39%)
children were reviewed.
M typing was available for 41 (42%) of all GAS
bacteraemia isolates. The most common M types
were M3 (29%), M28 (12%), M1 (10%) and M13
(7%). Common T types were T3 ⁄ 13 ⁄B3264 (40%),
T1 (9%), T12 and T28 ⁄ 56 (8%). There was no
signiﬁcant difference in M and T types between
children and adults.
The annual number of cases of GAS bacterae-
mia varied from three to 24 cases ⁄ year, with an
unexplained peak in the year 2000 (Fig. 1). M
typing (available for only eight of the 24 isolates
from 2000) showed heterogeneous strains in all
but two cases. No cyclic pattern or seasonal
variation was observed. Most cases were seen in
adults, although GAS bacteraemia comprised
3.3% of paediatric bacteraemias, compared to
0.6% in adults (p < 0.001) (Fig. 2). The overall
incidence of GAS bacteraemia was 13.3 ⁄ 1000
paediatric admissions, compared to 2 ⁄ 1000 adult
admissions (p < 0.001).
With the exceptionof twoadult patients, all cases
of GAS bacteraemia were community-acquired.
Antibiotic susceptibility data
All isolateswere shown to be sensitive to penicillin,
chloramphenicol and vancomycin by the Kirby–
Bauer method. Of 92 isolates tested, 17% were
resistant to tetracycline, with no change in the
frequency of resistance during the 10-year period
of the study, and 9%weremacrolide-resistant. The
ﬁrst macrolide-resistant isolate was detected in
1999, and the frequency of resistance rose to 20% in
2000. Sensitivity to ﬂuoroquinolones was only
tested from 1997 onwards; thus, only 54 isolates
were tested. Ciproﬂoxacin resistance was detected
ﬁrst in 1999, and the frequency of resistance
reached 46% in 2002. These resistance patterns
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Fig. 1. Group A streptococcus bacteraemia: number of
cases ⁄year (1993–2002).
Megged et al. Group A streptococcus bacteraemia 157
 2005 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 156–162
ﬂuoroquinolones. Clindamycin susceptibility was
not tested routinely during the study period, as all
GAS strains are considered sensitive to clindamy-
cin. Of all patients treated with clindamycin, either
alone or in combination with b-lactam antibiotics,
none gave isolates resistant to erythromycin, so
inducible clindamycin resistance (‘D-shape’ inhi-
bition) appeared to be of no signiﬁcance.
Admitting departments
The 38 children were hospitalised in the various
units of the paediatric department. The 60 adults
were hospitalised in internal medicine (n = 43;
72%), the intensive care unit (n = 4; 7%), gynae-
cology (n = 6, 10%), general surgery (n = 3; 5%),
cardiology (n = 2; 3%), orthopaedics (n = 1; 2%)
and plastic surgery (n = 1; 2%).
Clinical characteristics of patients with
group A streptococcus bacteraemia
Table 1 compares the main clinical and laboratory
ﬁndings for the 60 adults and 38 children with
GAS bacteraemia. Overall, the mean age of the
patients was 39 (± 34) years, with children aged
from 1 week to 13 (mean 1.7 ± 2.2) years, and
adults aged from 19 to 96 (mean 63 ± 21) years.
Fifty-one (52%) of the patients were male.
Seven (18%) of 38 children were coinfected
with varicella, and had concomitant focal infec-
tion (two cellulitis, two pneumonia, one osteo-
myelitis, one otitis media and one severe
stomatitis). Two patients had necrotising fasciitis,
and seven patients met the criteria for toxic shock
syndrome. Seven patients had a rash characteris-
tic of streptococcal infection. Five women had
peripartum infection.
Underlying conditions
Fifty-eight patients (88% of adults and 13% of
children) had underlying conditions. The most
common concomitant conditions in adults were
ischaemic heart disease (n = 14), insulin-depend-
ent diabetes mellitus (n = 10) and hypertension
(n = 8). Only ﬁve children had underlying condi-
tions: one had asthma, one had trisomy 21, one
had congenital heart disease, and two had a
history of premature birth.
Source of infection
Seventy-six (78%) patients had an identiﬁed












Fig. 2. Cases of group A streptococcus bacteraemia as a
percentage of all cases of bacteraemia.
Table 1. Clinical and laboratory
characteristics of adults and chil-




Mean ± SD (n)
Adults
Mean ± SD (n)
Children
Mean ± SD (n) p
Fever (C) 38.8 ± 1.1 (96) 38.4 ± 1.1 (59) 39.4 ± 0.7 (37) < 0.001
Time to defervescence (days) 3 ± 3.9 (86) 4 ± 2.7 (58) 3.7 ± 6.4 (26) 0.28
Duration of hospitalisation (days) 12.3 ± 11.2 (90) 13.4 ± 11.3 (59) 10.1 ± 10.7 (31) 0.18
WBC count (cells ⁄mm3) 16 468 ± 7942 (98) 15 995 ± 8791 (60) 18 237 ± 6697 (38) 0.18
Lymphocytes (%) 14 ± 14.2 (89) 7.5 ± 5.9 (53) 23.5 ± 17.3 (36) < 0.001
Platelets (· 103 ⁄mm3) 251 ± 157 (98) 208 ± 105 (60) 320 ± 154 (38) < 0.001
Haemoglobin (g ⁄dL) 11.7 ± 1.8 (98) 11.7 ± 1.8 (60) 11.7 ± 1.8 (38) 0.98
ESR (mm ⁄h) 70 ± 37 (64) 78 ± 36 (36) 59 ± 37 (28) < 0.05
Calcium (mg ⁄dL) 8.9 ± 0.8 (64) 8.8 ± 0.7 (45) 9.1 ± 1 (19) 0.2
Creatinine (mg ⁄dL) 1 ± 0.9 (93) 1.39 (57) 0.4 (36) NAa
pH 7.35 ± 0.1 (48) 7.34 ± 0.1 (27) 7.35 ± 0.04 (21) 0.7
DIC, n (%) (N*) 9, 10.1 (89) 6, 10.7 (56) 3, 9.1 (33) 0.91
TSS, n (%) (N*) 7, 7.1 (98) 5, 8.3 (60) 2, 5.3 (38) 0.86
Death, n (%) (N*) 12, 12.2 (98) 11, 18.3 (60) 1, 2.6 (38) 0.03
WBC, white blood cell; ESR, erythrocyte sedimentation rate; DIC, disseminated intravascular coagulation; TSS, toxic
shock syndrome; N*, number of patients with data available.
aComparison not applicable due to different normal range.
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one site. The associated focal infections are listed
in Table 2. Forty-seven (48%) patients had a skin
or soft-tissue infection of at least one site. In most
patients, the skin or soft-tissue infection was
diagnosed solely on clinical grounds, without
corresponding microbiological ﬁndings. In nine
(19%) patients, GAS was isolated from an addi-
tional site: pleura (n = 1), ear (n = 1), peritoneum
(n = 1), pericardium (n = 1), synovium (n = 2),
vagina (n = 2) and sputum (n = 1).
Treatment regimens
Sixty-eight patients were treated with b-lactam
antibiotics only, nine with clindamycin only, and
17 with both b-lactams and clindamycin. Four
patients were treated with other antibiotics. There
was no correlation between antibiotic treatment
and mortality. Only two patients, one of whom
died, received intravenous immunoglobulins.
Clinical and laboratory results of adults
compared with children
Children presented with signiﬁcantly higher
fever (39.4 ± 0.7C vs. 38.4 ± 1.1C; p < 0.001)
and platelet counts (320 ± 154 · 103 vs.
208 ± 105 · 103; p < 0.001) than adults (Table 1).
Erythrocyte sedimentation rates were signiﬁ-
cantly lower in children (59 ± 37 vs.
78 ± 36 mm ⁄ h, p < 0.05), as was mortality
(2.6% vs. 18.3%, p 0.03). Children had fewer
neutrophils in their leukocyte counts (mean
neutrophil count 63.3% ± 21.4 vs. 86.5% ± 8.6;
p < 0.001), although there was no signiﬁcant
difference in total white blood cell counts between
children and adults (18 237 ± 6697 vs.
15 995 ± 8791; p 0.18). There were no statistically
signiﬁcant differences between children and
adults with respect to gender, toxic shock
syndrome, disseminated intravascular coagula-
tion, need for surgery, number of previous days
of illness, length of hospitalisation, rash other
than that of varicella, days to defervescence, or
antibiotic treatment. T and M types, leukocyte
counts, and levels of haemoglobin, calcium,
pH ⁄ bicarbonate, creatine phosphokinase and
liver enzymes were also similar.
Mortality and morbidity
The overall mortality rate was 12%. Three
patients who survived had long-term morbidity;
two adults underwent amputations and one child
had severe neurological sequelae. Ten patients
required surgical intervention; two adult patients
with fasciitis required amputation, and eight
patients (two children and six adults, p 0.5)
underwent drainage of a soft-tissue abscess or a
joint.
Factors associated with improved outcome
The factors inﬂuencing outcome in bivariate
analysis are listed in Table 3. Survivors were
younger than non-survivors (p 0.027). Fever was
higher in survivors by a mean of 1.1C (p 0.001),
but there was no correlation with hypothermia.
Multivariate analysis showed that only the fol-
lowing variables were signiﬁcant in predicting a
poor outcome: higher fever (p 0.005); number of
surgical procedures (p 0.007); thrombocytopenia
(p 0.05); and hypocalcaemia (p 0.04). The follow-
ing variables did not show any correlation with
outcome: gender; year and month of occurrence
of the infection; underlying conditions; rash;
antibiotic treatment regimen; treatment with
intravenous immunoglobulins; M or T type; total
white cell count; haemoglobin level; erythrocyte
sedimentation rate; heart rate; duration of illness;
length of hospitalisation; days to defervescence;
liver enzyme levels; and creatine phosphokinase
level.
DISCUSSION
This 10-year study of 98 patients with GAS
bacteraemia found that children comprised 39%
Table 2. Associated tissue involvement in patients with






Cellulitis 11 (29) 34 (57) 0.008
Fasciitis 1 (3) 1 (2) 1
Arthritis 2 (5) 4 (7) 1
Osteomyelitis 3 (8) 1 (2) 0.296
Tonsillitis 4 (10) 0 (0) 0.02
Lymphadenitis 2 (5) 0 (0) 0.148
Otitis media 5 (13) 0 (0) 0.007
Pneumonia 2 (5) 10 (17) 0.12
Pericarditis 1 (3) 0 (0) 0.388
Peritonitis 2 (5) 0 (0) 0.148
Chorioamnionitis 0 (0) 2 (3) 0.52
No focal infectiona 7 (18) 8 (13) 0.694
Total 40b 60
aOrganism isolated only from blood and not another site.
bTwo children had the organism isolated from two sites.
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of all patients. This is a relatively high percentage
in comparison with previous studies, in which the
proportion of paediatric patients ranged from 16
to 32% [9–14]. Only two studies have reported a
similar proportion of paediatric patients [15,16].
Zurawski et al. [17] and Eriksson et al. [18] have
reported that the incidence of GAS bacteraemia
increases with age, and is highest in individuals
aged > 65 years. The high proportion of children
in the present series cannot be attributed to high
numbers of paediatric patients admitted to this
institution, since the rate of paediatric GAS bac-
teraemia was 13.3 cases ⁄ 1000 hospitalisations,
compared with 2.0 for adults (p < 0.001). In
addition, the rate of GAS bacteraemia among all
bacteraemias was higher in children than in adults
(3.3% vs. 0.6%). A possible explanation may be
the overcrowding and low socio-economic status
of certain populations in Jerusalem [19,20], which
may contribute to the high incidence of GAS
pharyngitis and associated complications. Crow-
ded living conditions and low vaccination rates
against varicella also account for the high inci-
dence of varicella infection in Jerusalem [12]. The
association between invasive GAS disease and
varicella infection has been described previously
[21–23], and contributed to the development of
GAS bacteraemia in seven (18%) of the 38 paedi-
atric patients in the present study.
The overall mortality rate was 12%, which was
lower than has been reported previously (15–
48%) [1,9,12,13,20,24–27]. Reported mortality is
high (up to 67%) in patients with toxic shock
syndrome [13,24]. The decrease in mortality rate
over the years is probably related to increased
awareness of GAS bacteraemia and its complica-
tions, and to better supportive treatment modal-
ities. There were fewer fatalities in children in the
present series (2.6% in children vs. 18% in adults;
p 0.03), a ﬁnding consistent with those of other
studies [4,14,16,18]. Fewer children developed
toxic shock syndrome, as deﬁned by the Working
Group Classiﬁcation Scheme [28] (5% of children
vs. 8% of adults; p 0.86), a ﬁnding similar to that
reported in most [12,29], but not all [13,30], other
paediatric series. Since there was no difference in
streptococcal M or T types, it is unlikely that the
difference between children and adults derives
from variations in the virulence of bacterial
strains. More likely, the difference is related to
host factors such as repeated exposure to GAS
infection leading to improved humoral protection
in children, and the lack of underlying, compli-
cating conditions, characteristic of the elderly.
In contrast to previous studies, a cyclical
pattern in GAS bacteraemia was not identiﬁed,
there was no increase in the incidence of GAS
bacteraemia during the study period, and
seasonal variation was not demonstrated
[1,3,7,8,25,30–32]. However, there was an unex-
plained peak in cases of GAS bacteraemia in 2000,
primarily in children, with no rise in the number
of bacteraemias caused by other organisms.
Unfortunately, no data were available regarding
the incidence of GAS infection in the community,
but there was no information suggesting an
epidemiological connection between the cases,
with no predominant M or T type among the
isolates from 2000. Similar unexplained peaks in
infection have been described previously [3,30].
As in previous reports [4,5,12,13,27,33], soft-
tissue infection was the source of infection
identiﬁed most commonly in both adults and
children. Seven children were coinfected with
varicella, which is a well-known predisposing
condition for invasive streptococcal infection [29],
possibly because of disruption of the skin’s
integrity and ⁄ or other immunological factors.
Hence, it has become common practice to consi-
der early antibiotic treatment for children with
varicella who develop secondary cellulitis, scar-
latiniform rash and ⁄ or a toxic appearance.
The present study had several limitations. First,
patients were identiﬁed only by a positive blood
culture. Thus, patients with severe, invasive GAS
infections, such as necrotising fasciitis or toxic
shock syndrome, without bacteraemia were not
included. Since the pathogenesis of severe GAS
infection is mediated by exotoxins, an invasive,
Table 3. Variables associated with mortality in patients





n = 12 p
DIC % 96 5.8 33.3 0.008
Surgical procedures 98 7 3 0.018
TSS % 98 3.5 33.3 0.004
Fever (C) 96 38.9 ± 1.0 37.8 ± 1.2 0.003
Age (years) 98 36.4 ± 34.1 60.7 ± 28.0 0.027
Systolic BP (mm Hg) 88 111 ± 29 92 ± 37 0.047
Lymphocytes % 89 15.2 ± 14.7 4.7 ± 2.9 0.002
Platelets (· 103 ⁄ lL) 98 260 ± 135 185 ± 136 0.044
Calcium (mg ⁄dL) 64 9.0 ± 0.7 8.2 ± 1.0 0.006
Creatinine (mg ⁄dL) 93 0.9 ± 0.8 2.0 ± 1 < 0.001
Blood pH 48 7.4 ± 0.06 7.3 ± 0.1 0.102
aNumber shown for each variable is the number of patients with available data.
BP, blood pressure; DIC, disseminated intravascular coagulation; TSS, toxic shock
syndrome.
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and even fatal, GAS infection is often not associ-
ated with bacteraemia. In many studies, these
cases are included and analysed together with
cases of bacteraemia [3,5,6,8,10,12,14,17,18,22,
30,33,34]. Thus, it is possible that the results
of this study do not reﬂect the entire spectrum of
invasive GAS infection. Second, because of the
retrospective nature of the study, some data were
not available for all study patients, thus limiting
the power of the analysis for those variables.
Nevertheless, in contrast to previous studies, the
relative incidence of GAS bacteraemia was signi-
ﬁcantly higher in children than in adults, which is
a surprising ﬁnding that is not fully understood.
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